Clinical Trial: TAF vs TDF During the Pregancy

U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07542951) titled 'TAF vs TDF During the Pregancy' on April 09.

Brief Summary: The goal of this clinical trial is to learn the efficacy and safety of Tenofovir alafenamide (TAF) vs Tenofovir disoproxil fumarate(TDF) in early and middle pregnancy antiviral therapy for chronic hepatitis B pregnant women.

The main questions it aims to answer are:

The rate of HBV mother-to-child transmission between the TAF and TDF groups. The incidence of birth defects in newborns between the TAF and TDF groups. What medical problems do participants have when taking drug TAF or TDF? The growth and development indices of newborns between the TAF and TDF groups.

Partic...